In the setting of AMI, it has been shown that the administration of recombinant HMGB1 aggravates acute myocardial IRI, suggesting the involvement of RAGE in the post-MI inflammatory response (Andrassy et al., 2008). Here, AGER is linked to myocardial infarction.